Author

J. W. Karlsson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

J. A. Nilsson· 2 shared L. Ny· 2 shared R. Olofsson Bagge· 2 shared S. Alsen· 2 shared A. E. Hemminki· 1 shared A. Saxena· 1 shared E. M. Forsberg· 1 shared H. Ronnberg· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. A. Nilsson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivMay 16, 2023

Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases

J. W. Karlsson, V. R. Sah, R. Olofsson Bagge…·J. A. Nilsson

DOI 10.7554/elife.91705

𝕏 PostBluesky

Cancer BiologyCancersPeer-reviewedJan 20, 2023

Treatment with anti-HER2 chimeric antigen receptor tumor-infiltrating lymphocytes (CAR-TILs) is safe and associated with antitumor efficacy in mice and companion dogs

E. M. Forsberg, R. Riise, S. Saellstrom…·J. A. Nilsson

This study evaluates the safety and antitumor efficacy of anti-HER2 CAR-TILs in mice and dogs, showing tumor eradication and tolerability.

DOI 10.3390/cancers15030648

𝕏 PostBluesky